| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Catalent Inc (NYSE: CTLT)
CTLT Technical Analysis
5
| As on 9th Jun 2023 CTLT STOCK Price closed @ 38.81 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 95.77 & Strong Sell for SHORT-TERM with Stoploss of 107.67 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CTLTSTOCK Price
| Open | 39.25 | Change | Price | % |
| High | 40.11 | 1 Day | -0.19 | -0.49 |
| Low | 38.48 | 1 Week | 1.58 | 4.24 |
| Close | 38.81 | 1 Month | -8.14 | -17.34 |
| Volume | 4493800 | 1 Year | -85.72 | -68.83 |
| 52 Week High 128.51 | 52 Week Low 31.86 | ||||
NYSE USA Most Active Stocks
| DDR | 15.44 | -4.46% |
| NIO | 7.73 | -0.77% |
| TWTR | 53.70 | 0.66% |
| CVNA | 19.07 | -21.30% |
| BACA-U | 302.00 | 0.67% |
| PLTR | 15.02 | -1.12% |
| F | 13.74 | 1.18% |
| CS | 0.89 | 1.14% |
| RPAI | 13.15 | -3.17% |
| AUY | 5.85 | -0.68% |
NYSE USA Top Gainers Stocks
NYSE USA Top Losers Stocks
| CTLT Daily Charts |
CTLT Intraday Charts |
Whats New @ Bazaartrend |
CTLT Free Analysis |
|
|
CTLT Important Levels Intraday
| RESISTANCE | 41.95 |
| RESISTANCE | 40.94 |
| RESISTANCE | 40.32 |
| RESISTANCE | 39.70 |
| SUPPORT | 37.92 |
| SUPPORT | 37.30 |
| SUPPORT | 36.68 |
| SUPPORT | 35.67 |
CTLT Forecast April 2024
| 4th UP Forecast | 85.62 |
| 3rd UP Forecast | 70.61 |
| 2nd UP Forecast | 61.33 |
| 1st UP Forecast | 52.05 |
| 1st DOWN Forecast | 25.57 |
| 2nd DOWN Forecast | 16.29 |
| 3rd DOWN Forecast | 7.01 |
| 4th DOWN Forecast | -8 |
CTLT Weekly Forecast
| 4th UP Forecast | 63.57 |
| 3rd UP Forecast | 55.63 |
| 2nd UP Forecast | 50.72 |
| 1st UP Forecast | 45.81 |
| 1st DOWN Forecast | 31.81 |
| 2nd DOWN Forecast | 26.90 |
| 3rd DOWN Forecast | 21.99 |
| 4th DOWN Forecast | 14.05 |
CTLT Forecast2024
| 4th UP Forecast | 228.2 |
| 3rd UP Forecast | 167.46 |
| 2nd UP Forecast | 129.92 |
| 1st UP Forecast | 92.37 |
| 1st DOWN Forecast | -14.75 |
| 2nd DOWN Forecast | -52.3 |
| 3rd DOWN Forecast | -89.84 |
| 4th DOWN Forecast | -150.58 |
Catalent Inc ( NYSE USA Symbol : CTLT )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CTLT Business Profile
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. It operates through four segments: Biologics, Softgel and Oral Technologies, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations. The Biologics segment provides biologic cell-line; develops and manufactures cell therapy and viral based gene therapy; formulation, development, and manufacturing for parenteral dose forms, including vials, prefilled syringes, vials, and cartridges; and analytical development and testing services. The Oral and Specialty Delivery segment offers formulation, development, and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. This segment also offers oral delivery solutions platform comprising pre-clinical screening, formulation, analytical development, and current good manufacturing practices services. The Clinical Supply Services segment offers manufacturing, packaging, storage, distribution, and inventory management for drugs and biologics clinical trials. It also offers FastChain demand-led clinical supply services. The company serves pharmaceutical, biotechnology, and consumer health companies; and companies in other healthcare market segments, such as animal health and medical devices, as well as in cosmetics industries. Catalent, Inc. was incorporated in 2007 and is headquartered in Somerset, New Jersey. Address: 14 Schoolhouse Road, Somerset, NJ, United States, 08873
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service